Replies to post #172 on PDL BioPharma Inc. (PDLI)

[surf1944]

7:07AM PDL BioPharma prices $260.87 mln aggregate principal amount of its 4.00% Convertible Senior Notes due Feb 1, 2018 in an underwritten public offering (PDLI) 7.97 : The conversion rate of the Notes will initially be 109.1048 shares of common stock per $1,000 principal amount of the Notes equivalent to an initial conversion price of ~ $9.17 per share of common stock.